Versartis Stock Price (NASDAQ:VSAR)

Add to My Stocks
$2.03 $0.03 (1.5%) VSAR stock closing price Jul 20, 2018 (Closing)
Prev Close* : $2
Market Cap:
$72.16M
Day Low: $2
52 Week Low: $1.35
Open: $2
Volume: -
Day High: $2.05
52 Week High: $22.10
Dividend:
0.00

Latest Stock Market News

Latest Articles

Versartis News - From Partners

VSAR Stockcharts

View VSAR PE ratio, PS ratio stocks charts and compare with peers.
VSAR Chart
Note: Compare Versartis stock price history with the index and industry peers.

Versartis Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
-999.0000
PB ratio (
price to book ratio
)
-999.0000

Versartis Returns

ROE
(return on equity)

Versartis Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield
-999.0000

VSAR Industry Peers

Company Price Change (%)
Zynerba Pharma (ZYNE)7.912.51 (24.09%)
Sol Gel Tech (SLGL)6.980.13 (1.9%)
Opko Health (OPK)5.890.07 (1.17%)
Ascendis Pharma (ASND)69.181.67 (2.36%)
Novo Nordisk (NVO)50.440.63 (1.26%)
Capstone Therapeutics Corp. (CAPS)0.050 (0%)
Ascendis Pharma (ASND)69.181.67 (2.36%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Teligent (TLGT)4.220.21 (5.24%)
Dr. Reddy's Laboratories (RDY)29.660.41 (1.4%)
Supernus Pharma (SUPN)54.8750.63 (1.16%)
Akorn (AKRX)17.470.16 (0.92%)
Top gainers from Medical-Generic Drugs industry
* As of Jul 20, 2018
CompanyPriceChange (%)
Progenics Pharma (PGNX)8.260.13 (1.55%)
Mallinckrodt (MNK)21.660.24 (1.1%)
Allergan (AGN)171.791.6 (0.92%)
Corium (CORI)7.890.07 (0.88%)
Teva Pharmaceutical (TEVA)22.930.13 (0.56%)
AxoGen (AXGN)550.2 (0.36%)
Mylan (MYL)35.530.11 (0.31%)
Top losers from Medical-Generic Drugs industry
* As of Jul 20, 2018

Versartis Inc Stock News - Partner Headlines

Versartis Financial Statements

income statement20172016201520142013
Net Sales or Revenues40M----
Net Income-84.97M-95.81M-82.17M-57.51M-18.49M
Total Operating Expense124.48M96.31M82.5M46.1M19.27M
View Versartis income statement
balance sheet20172016201520142013
Total Assets93.77M205.57M185.32M174.29M14.68M
Total Liabilities11.02M54.5M8.82M6.92M4.47M
Shareholders Equity82.75M151.06M176.5M167.36M10.2M
View Versartis balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-44.97M44.04M2.22M1.24M1.97M
Net Cash from (used by) Operating Activities-116.28M-40.63M-69.06M-39.65M-17.09M
Increase (Decrease) in Prop Plant And Equipment-4.3M-0.09M--0.82M-0.01M
View Versartis cash flow statement

Versartis Stock Message Board

An investor needs to spend $2.03 to buy VSAR stock, as the closing Versartis stock price is $2.03. The total market value as denoted by $72.16M for Versartis, is the market value of the company's outstanding shares. Versartis valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Versartis is worth a lot, it will most likely be reflected in an inflated Versartis stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume of shares traded stood at 117,057 on the last trading day, as is evident from Versartis stock chart, and VSAR stock quote data. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Versartis stock dividend was 0.00 during the last quarter. To check the historical stock price movement, all time high, and all time low of VSAR, view Versartis stock price history.